Variant report
Variant | nsv971312 |
---|---|
Chromosome Location | chr8:59413234-59417187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr8:59412484-59413478 | HepG2 | liver: | n/a | n/a |
2 | KAP1 | chr8:59413844-59414358 | K562 | blood: | n/a | n/a |
3 | MAFF | chr8:59416550-59416623 | K562 | blood: | n/a | chr8:59416604-59416618 chr8:59416598-59416616 |
4 | MAFF | chr8:59416453-59416772 | HepG2 | liver: | n/a | chr8:59416604-59416618 chr8:59416598-59416616 |
5 | MAFK | chr8:59416417-59416754 | HepG2 | liver: | n/a | chr8:59416436-59416447 chr8:59416603-59416619 chr8:59416604-59416618 chr8:59416601-59416621 |
6 | MAFK | chr8:59416430-59416773 | HepG2 | liver: | n/a | chr8:59416436-59416447 chr8:59416603-59416619 chr8:59416604-59416618 chr8:59416601-59416621 |
7 | MAFK | chr8:59416537-59416734 | K562 | blood: | n/a | chr8:59416603-59416619 chr8:59416604-59416618 chr8:59416601-59416621 |
8 | NFIC | chr8:59412580-59413292 | HepG2 | liver: | n/a | n/a |
9 | STAT3 | chr8:59413620-59413633 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | TCF7L2 | chr8:59412700-59413492 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:59413577-59413627 | AoSMC | blood vessel: | n/a |
2 | chr8:59413577-59413627 | NB4 | blood: | n/a |
3 | chr8:59413577-59413627 | NHDF-neo | bronchial: | n/a |
4 | chr8:59413577-59413627 | K562 | blood: | n/a |
5 | chr8:59413577-59413627 | MCF-7 | breast: | n/a |
6 | chr8:59413577-59413627 | AG04449 | skin: | fetal |
7 | chr8:59413577-59413627 | HMEC | breast: | n/a |
8 | chr8:59413577-59413627 | Jurkat | blood: | n/a |
9 | chr8:59413577-59413627 | HCM | heart: | n/a |
10 | chr8:59413577-59413627 | SK-N-MC | brain: | n/a |
11 | chr8:59413577-59413627 | Hela-S3 | cervix: | n/a |
12 | chr8:59413577-59413627 | ECC-1 | luminal epithelium: | n/a |
13 | chr8:59413577-59413627 | HRCEpiC | kidney: | n/a |
14 | chr8:59413577-59413627 | HAEpiC | amniotic membrane: | n/a |
15 | chr8:59413577-59413627 | LNCaP | prostate: | n/a |
16 | chr8:59413577-59413627 | SK-N-SH | brain: | n/a |
17 | chr8:59413577-59413627 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr8:59413577-59413627 | U87 | brain: | n/a |
19 | chr8:59413577-59413627 | HRPEpiC | eye: | n/a |
20 | chr8:59413577-59413627 | AG09309 | skin: | n/a |
21 | chr8:59413577-59413627 | PrEC | prostate: | n/a |
22 | chr8:59413577-59413627 | HepG2 | liver: | n/a |
23 | chr8:59413577-59413627 | PANC-1 | pancreas: | n/a |
24 | chr8:59413577-59413627 | HNPCEpiC | eye: | n/a |
25 | chr8:59413577-59413627 | NHBE | bronchial: | n/a |
26 | chr8:59413577-59413627 | T-47D | breast: | n/a |
27 | chr8:59413577-59413627 | GM12892 | blood: | n/a |
28 | chr8:59413577-59413627 | BE2_C | brain: | n/a |
29 | chr8:59413577-59413627 | AG09319 | gingival: | n/a |
30 | chr8:59413577-59413627 | PFSK-1 | brain: | n/a |
31 | chr8:59413577-59413627 | HCF | heart: | n/a |
32 | chr8:59413577-59413627 | SAEC | small airway: | n/a |
33 | chr8:59413577-59413627 | SK-N-SH_RA | brain: | n/a |
34 | chr8:59413577-59413627 | HEEpiC | esophagus: | n/a |
35 | chr8:59413577-59413627 | GM12878 | blood: | n/a |
36 | chr8:59413577-59413627 | AG04450 | lung: | fetal |
37 | chr8:59413577-59413627 | GM06990 | blood: | n/a |
38 | chr8:59413577-59413627 | A549 | lung: | n/a |
39 | chr8:59413577-59413627 | NT2-D1 | testis: | n/a |
40 | chr8:59413577-59413627 | ovcar-3 | ovarian: | n/a |
41 | chr8:59413577-59413627 | MCF10A-Er-Src | breast: | n/a |
42 | chr8:59413577-59413627 | HCPEpiC | choroid plexus: | n/a |
43 | chr8:59413577-59413627 | AG10803 | skin: | n/a |
44 | chr8:59413577-59413627 | GM12891 | blood: | n/a |
45 | chr8:59413577-59413627 | IMR90 | lung: | fetal |
46 | chr8:59413577-59413627 | BJ | skin: | n/a |
47 | chr8:59413577-59413627 | Caco-2 | colon: | n/a |
48 | chr8:59413577-59413627 | HIPEpiC | eye: | n/a |
49 | chr8:59413577-59413627 | ProgFib | skin: | n/a |
50 | chr8:59413577-59413627 | HL-60 | blood: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYP7A1 | TF binding region |
ENSG00000254103 | TF binding region |
CYP7A1 | CpG island |
ENSG00000254103 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371562549 | chr8:59413246-59413247 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs113548744 | chr8:59413300-59413301 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs543709786 | chr8:59413316-59413317 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs563291262 | chr8:59413322-59413323 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs573496440 | chr8:59413384-59413385 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs561222214 | chr8:59413420-59413421 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs181500014 | chr8:59413475-59413476 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs559006411 | chr8:59413533-59413534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528199502 | chr8:59413613-59413614 | Weak transcription Enhancers | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs577118181 | chr8:59413622-59413623 | Weak transcription Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs186620537 | chr8:59413623-59413624 | Weak transcription Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs533048312 | chr8:59413648-59413649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112025687 | chr8:59413713-59413714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533415836 | chr8:59413728-59413729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550449460 | chr8:59413730-59413731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543110498 | chr8:59413805-59413806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570404468 | chr8:59413842-59413843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536043642 | chr8:59413846-59413847 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs190139312 | chr8:59413927-59413928 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs566150868 | chr8:59413998-59413999 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs370452053 | chr8:59414011-59414012 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs7840733 | chr8:59414061-59414062 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs557826173 | chr8:59414072-59414073 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs577972283 | chr8:59414104-59414105 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs537097076 | chr8:59414151-59414152 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs563400199 | chr8:59414165-59414166 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs557211228 | chr8:59414167-59414168 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs556299643 | chr8:59414203-59414204 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs573632000 | chr8:59414223-59414224 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs186741185 | chr8:59414228-59414229 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs73684310 | chr8:59414276-59414277 | Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs576243874 | chr8:59414284-59414285 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs572566414 | chr8:59414303-59414304 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs545094341 | chr8:59414326-59414327 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs79709216 | chr8:59414327-59414328 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs530519277 | chr8:59414344-59414345 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs12542233 | chr8:59414401-59414402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs62512761 | chr8:59414427-59414428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563951674 | chr8:59414447-59414448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149842689 | chr8:59414507-59414508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549565972 | chr8:59414522-59414523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147542155 | chr8:59414532-59414533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191201246 | chr8:59414541-59414542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551160028 | chr8:59414578-59414579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375536546 | chr8:59414614-59414615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139822983 | chr8:59414615-59414616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537436883 | chr8:59414650-59414651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562018433 | chr8:59414662-59414663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145356212 | chr8:59414825-59414826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567193460 | chr8:59414889-59414890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:59410000-59415200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr8:59411800-59413800 | Enhancers | HepG2 | liver |
3 | chr8:59411800-59418400 | Weak transcription | Psoas Muscle | Psoas |
4 | chr8:59413200-59414000 | Enhancers | Liver | Liver |
5 | chr8:59415200-59415600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr8:59415600-59416400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr8:59416200-59416600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr8:59416200-59417400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
9 | chr8:59416200-59419000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr8:59416400-59416600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr8:59416400-59416600 | Enhancers | Pancreas | Pancrea |
12 | chr8:59416400-59417800 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr8:59416400-59418200 | Enhancers | HSMMtube | muscle |
14 | chr8:59417000-59418200 | Enhancers | Stomach Smooth Muscle | stomach |